Región Metropolitana de Santiago
Este organismo compró $35.329.096.472 en 11.633 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Sur Medical SpA.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $1367,1 M |
| 2025 | $2402,7 M |
| 2024 | $2107,2 M |
| 2023 | $2816,8 M |
| 2022 | $1338 M |
| 2021 | $1018,6 M |
| 2020 | $888,8 M |
| 2019 | $901,2 M |
| 2018 | $1471,2 M |
| 2017 | $786,1 M |
| 2016 | $14,2 mil M |
| 2015 | $919,8 M |
| 2014 | $428,8 M |
| 2013 | $340,8 M |
| 2012 | $359,5 M |
| 2011 | $701,4 M |
| 2010 | $913,7 M |
| 2009 | $590,7 M |
| 2008 | $571,8 M |
| 2007 | $1180,7 M |
| 2006 | $34,7 M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 2980-141-AG26 | 19-03-2026 | Novartis Chile S.A. | Recepcion Conforme | $2.781.487 |
| 2980-142-AG26 | 19-03-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $896.457 |
| 2980-143-AG26 | 19-03-2026 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-145-AG26 | 19-03-2026 | Johnson y Johnson de Chile S.A. | Recepcion Conforme | $6.669.902 |
| 2980-146-AG26 | 19-03-2026 | Johnson y Johnson de Chile S.A. | Aceptada | $5.002.427 |
| 2980-147-AG26 | 19-03-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $368.097 |
| 2980-159-TD26 | 19-03-2026 | Juan Ramirez Briones y Compania Limitada | Recepcion Conforme | $2.955.960 |
| 2980-148-AG26 | 19-03-2026 | Inversiones Sb S.A. | Aceptada | $1.455.846 |
| 2980-153-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $10.647.354 |
| 2980-157-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $16.659.354 |
| 2980-154-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $1.594.646 |
| 2980-156-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $166.940 |
| 2980-155-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $5.787.921 |
| 2980-151-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $15.685.204 |
| 2980-158-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $3.190.221 |
| 2980-152-SE26 | 19-03-2026 | Fundacion Dr Jorge Perez Rifo | Recepcion Conforme | $5.012.251 |
| 2980-149-TD26 | 18-03-2026 | Contratista Jenifer Paola Bustamante Cornejo Empresa Individual de Responsabilid | Recepcion Conforme | $2.183.784 |
| 2980-150-TD26 | 18-03-2026 | Powerfilms SpA | Recepcion Conforme | $1.798.316 |
| 2980-121-AG26 | 16-03-2026 | Novartis Chile S.A. | Recepcion Conforme | $5.395.291 |
| 2980-122-AG26 | 16-03-2026 | Bristol Myers Squibb de Chile Agenc de e R Squibb & Sons Interam Corpo | Recepcion Conforme | $2.360.805 |
| 2980-123-AG26 | 16-03-2026 | Gador Limitada | Recepcion Conforme | $1.166.200 |
| 2980-124-AG26 | 16-03-2026 | Abbvie Productos Farmaceuticos Limitada | Recepcion Conforme | $1.392.300 |
| 2980-125-AG26 | 16-03-2026 | Novartis Chile S.A. | Recepcion Conforme | $2.927.257 |
| 2980-126-AG26 | 16-03-2026 | Laboratorios Andromaco S.A. | Recepcion Conforme | $2.627.520 |
| 2980-127-AG26 | 16-03-2026 | Gador Limitada | Recepcion Conforme | $3.498.600 |
| 2980-128-AG26 | 16-03-2026 | Novartis Chile S.A. | Recepcion Conforme | $4.716.379 |
| 2980-129-AG26 | 16-03-2026 | Bayer S.A. | Recepcion Conforme | $6.735.909 |
| 2980-130-AG26 | 16-03-2026 | Pharmaxpress SpA | Recepcion Conforme | $1.414.910 |
| 2980-131-AG26 | 16-03-2026 | Glaxosmithkline Chile Farmaceutica Limitada | Recepcion Conforme | $3.263.551 |
| 2980-133-AG26 | 16-03-2026 | Novofarma Service S.A. | Recepcion Conforme | $4.760.095 |
